key: cord-0616197-1cfrl4vh
authors: Han, Larry; Hou, Jue; Cho, Kelly; Duan, Rui; Cai, Tianxi
title: Federated Adaptive Causal Estimation (FACE) of Target Treatment Effects
date: 2021-12-17
journal: nan
DOI: nan
sha: 60eef5f1ac2db83ab6719f6a22b624738bcb21e4
doc_id: 616197
cord_uid: 1cfrl4vh

Federated learning of causal estimands may greatly improve estimation efficiency by leveraging data from multiple study sites, but robustness to heterogeneity and model mis-specifications is vital for ensuring validity. We develop a Federated Adaptive Causal Estimation (FACE) framework to incorporate heterogeneous data from multiple sites to provide treatment effect estimation and inference for a flexibly specified target population of interest. FACE accounts for site-level heterogeneity in the distribution of covariates through density ratio weighting. To safely incorporate source sites and avoid negative transfer, we introduce an adaptive weighting procedure via a penalized regression, which achieves both consistency and optimal efficiency. Our strategy is communication-efficient and privacy-preserving, allowing participating sites to only share summary statistics once with other sites. We conduct both theoretical and numerical evaluations of FACE, and apply it to conduct a comparative effectiveness study of BNT162b2 (Pfizer) and mRNA-1273 (Moderna) vaccines on COVID-19 outcomes in U.S. veterans using electronic health records from five VA regional sites. We show that compared to traditional methods, FACE meaningfully increases the precision of treatment effect estimates, with reductions in standard errors ranging from $26%$ to $67%$.

Multi-center, federated causal inference is of great interest, particularly when studying novel treatments, rare diseases, or in times of urgent health crises. For example, the COVID-19 pandemic has highlighted the need for novel approaches to efficiently and safely evaluate the effectiveness of novel therapies and vaccines, leveraging data from multiple healthcare systems to ensure the generalizability of findings. Over the past few years, many research networks and data consortia have been built to facilitate multi-site studies and have been actively contributing to COVID-19 studies, including the Observational Health Data Sciences and Informatics (OHDSI) consortium (Hripcsak et al. 2016 ) and the Consortium for Clinical Characterization of COVID-19 by EHR (Brat et al. 2020) .

Analyzing data collected from multiple healthcare systems, however, is highly challenging for several reasons. Various sources of heterogeneity exist in terms of (i) differences in the underlying population of each dataset and (ii) policy level variations of treatment assignment. Since treatment effects may differ across different patient populations, it would be of interest to infer the average treatment effect (ATE) for specific target populations. However, the presence of heterogeneity and potential model misspecification poses great difficulty to ensure valid estimates for the target average treatment effect (TATE). Furthermore, patient-level data typically cannot be shared across healthcare centers, which brings additional practical challenges. To overcome these challenges, we propose a Federated Adaptive Causal Estimation (FACE) framework that aims to incorporate heterogeneous data from multiple sites to make inference about the TATE, while accounting for heterogeneity and data-sharing constraints.

Most existing literature on federated learning has focused on regression and classification models (Chen et al. 2006 , Li et al. 2013 , Chen & Xie 2014 , Lee et al. 2017 , Lian & Fan 2017 , Wang et al. 2019 , Duan et al. 2019 . Limited federated learning methods currently exist to make causal inference with multiple heterogeneous studies. Recently, Xiong et al. (2021) proposed federated inverse probability weighted (IPW) estimation of the ATE specifically for an entire study population. Although Xiong et al. (2021) provided multiple methods for point estimation and variance estimation, the choice of the proper method depends on prior knowledge about model homogeneity and specification, which are difficult to verify in practice. No empirical study in Xiong et al. (2021) was provided to test the robustness of the approach to the covariate shift assumption. In addition, their methods cannot be used to estimate the ATE of a target population that differs from the full study population. Vo et al. (2021) proposed a Bayesian approach that models potential outcomes as random functions distributed by Gaussian processes. Their focus is also on the population ATE rather than any particular target population, and their approach requires specifying parameters and hyperparameters of Gaussian processes and modeling betweensite covariate correlations through kernel functions, which can be numerically intensive.

Compared to these approaches, our approach estimates the TATE in a particular target population and accounts for the heterogeneity across populations without requiring prior information on the source data distribution or the validity of model specifications. Our approach further safeguards against incorporating source datasets that may introduce bias to the estimation of the TATE, known as negative transfer (Pan & Yang 2009 , Weiss et al. 2016 ).

Another related strand of literature concerns the generalizability and transportability of randomized clinical trials to EHR studies. For example, Stuart et al. (2011 Stuart et al. ( , 2015 Stuart et al. ( , 2018 assessed the generalizability of results from randomized trials to target populations of interest. Dahabreh et al. (2020) , Dong et al. (2020) , and Josey et al. (2020) all focused on extending inferences about treatments from a randomized trial to a new target population by using different weighting schemes. For a comprehensive review of statistical methods for generalizability and transportability, see Degtiar & Rose (2021) . However, to date, no literature in generalizability and transportability has sought to leverage observational data from a potentially large number of source sites in a data-adaptive manner to obtain unbiased, efficient, and robust estimation of target treatment effects.

The major contributions of FACE can be summarized as follows. First, FACE allows for flexibility in the specification of the target population. For example, the target population in a research network can be defined as the underlying population of a given healthcare center, or multiple healthcare centers that share certain properties (e.g., geographic location), or the overall population combining all sites. This flexibility provides stakeholders and policymakers at different levels with information on their respective target populations. Second, using a semiparametric density ratio weighting approach, FACE allows the distribution of covariates to be heterogeneous across sites. Third, FACE protects against negative transfer through an adaptive integration strategy which anchors on the target data and computes data-adaptive weights for source sites. In doing so, FACE can achieve optimal efficiency while maintaining consistency, and it is robust to the distribution of data and potential model mis-specifications in the source sites. Moreover, FACE is a communication-efficient federated algorithm that allows each participating site to keep their data stored locally and only share summary statistics once with other sites.

The remainder of the paper is organized as follows. In Section 2, we introduce the problem setting, notation, and assumptions required for identification of the TATE. In Section 3, we describe the proposed FACE framework for estimating the TATE. We introduce the in-site estimators based on the target population and source populations separately in Sections 3.1 and 3.2 and present the adaptive and distributed integration in Section 3.3. In Section 4, we provide the theoretical guarantees of FACE, including double robustness, asymptotic normality, and relative efficiency. In Section 5, we conduct extensive simulations for various numbers of sites, data generating mechanisms, and show robustness to mis-specification of different models. In Section 6, we apply FACE to conduct a comparative effectiveness study of COVID-19 vaccines using the EHRs from five federated Veterans Affairs (VA) sites. We conclude in Section 7 with key takeaways and directions for future research.

For the i-th observation, we denote the outcome as Y i ∈ R, the p-dimensional baseline covariate vector as X i = (X i1 , ..., X ip ) ∈ X ⊂ R p , and the indicator for binary treatment as A i ∈ {0, 1}. There are J ≥ 1 target sites and another K ≥ 0 source sites. Let T ⊆ [J +K] indicate sites that are in the target population and S ⊂ [J +K] indicate sites that are in the source population, where [K] = {1, ..., K} for any integer K. Under the federated learning setting, a total of N observations are stored at J + K study sites, where the k-th site has sample size n k , and N = J+K k=1 n k . Let R i be a site indicator such that R i = k indicates the i-th patient in the k-th site. Indexing the site by a single integer R i , we assume that each observation may only belong to one site. We summarize the observed data at each site k

and consider a federated data setting where each site has access to its own patient-level data but can share only summary statistics with other sites. We denote the index set for each site as I k = {i : R i = k}. The data included in the target sites are denoted by D T . For simplicity of notation, we use (Y, X, A, R) without subscripts to state general assumptions and conclusions.

Under the potential outcomes framework (Neyman 1923 , Rubin 1974 , we denote Y (a) as the potential outcome of patients under treatment A = a, a = 0, 1. Our goal is to estimate the TATE for a specified target population T ,

where the expectation is taken over the distribution in the target population. The target population can be specified at multiple levels (e.g., single site, multiple sites, all sites)

corresponding to different targets of real-world interest. This distinction between target and source sites also distinguishes our setting from that of Xiong et al. (2021) , in which the target population always contains all participating sites.

To identify the TATE, we make the following standard assumptions (Imbens & Rubin 2015 , Hernán & Robins 2020 ) throughout the paper:

Assumption 1. For a positive constant ε > 0, a ∈ {0, 1}, and x ∈ X , (a) Consistency: Y = Y (A) .

(b) Overlapping of treatment arms:

(c) Overlapping of site populations:

Remark 1. Assumption 1(d) implies that the underlying true treatment response pattern is shared across target sites and an unspecified subset of source sites S * ⊆ S so that the treatment effect estimates from T and S * can be safely combined to estimate the TATE.

Our adaptive selection and aggregation step in FACE, as detailed in Section 3.3, is designed to incorporate these source sites S * for precision gain while preventing negative transfer from other source sites S \ S * .

We denote the specified models for the site-specific propensity score (PS) and outcome regression (OR) as:

For the target sites, we require E(Y (a) | R = k, X) to be shared but do not require α k to be the same across T . Under possible model model mis-specifications, we allow either (i) the outcome models in (S.3) to be correctly specified with β a,k = β a , or (ii) the PS models in (S.2) to be correctly specified, for k ∈ T .

Since the distribution of the covariates X can be heterogeneous across sites, we characterize the difference in covariate distributions between a target site k t ∈ T and a source site k s ∈ S through a density ratio

.

We choose flexible semiparametric models for the density ratio ω k t ,ks (X; γ k t ,ks ) = exp{γ k t ,ks ψ(X)},

where ψ : R p → R q is a vector-valued basis function with an intercept term. One may specify a range of basis functions to capture potential non-linearity in the density ratio model to improve the robustness of the estimation for ω k t ,ks (x).

Remark 2. The exponential tilt density ratio model (S.4) is widely used to account for heterogeneity between two distributions (Qin 1998 , Qin & Liang 2011 , Duan et al. 2020b ).

By including higher-order terms of x in ψ(x), higher-order differences such as variance and skewness can be captured. We propose in Section 3 a communication-efficient approach to estimate γ k t ,ks in covariate distributions between a target site and source site without sharing individual-level data.

In this section, we detail the FACE method. We start with an overview of its main workflow, where a schematic illustration can be found in Figure S1 of the Supplementary Materials. In step 1, each target site calculates summary statistics of its covariate distribution, ψ k t = n −1 k t i∈I k t ψ(X i ), a key quantity for estimating the density ratio model to balance covariate distributions, and broadcasts them to all source sites, along with its OR parameters { β a,k , a = 0, 1}. Each target site also constructs a doubly robust estimator (Bang & Robins 2005) for its site-specific ATE, obtains additional summary statistics needed for the adaptive aggregation, and shares them with the leading analysis center (AC) (see Section 3.1). In Step 2, each source site uses ψ k t to fit its density ratio model and construct an augmentation term δ T ,ks for the TATE. Each source site shares the augmentation term, together with additional summary statistics needed for the aggregation, to the AC (see Section 3.2). In Step 3, the AC performs the aggregation with estimators and parameters from Steps 1 and 2 to obtain the final FACE estimator, ∆ T ,FACE (see Section 3.3). Overall, each site is only required to share information one time with other sites.

We detail each step of FACE in Sections 3.1-3.3 with generic models. Each site will need to fit both the OR models and the PS model using its own local data. Standard regression models such as logistic regression and generalized linear models can be used. Non-linear basis functions can be included to incorporate non-linear effects. For k ∈ [J +K], we denote the estimated PS as π k (a, X; α k ) and the predicted outcome for treatment a as m(a, X; β a ),

where α k and β a can be achieved via classical estimation methods such as maximum likelihood estimation or estimating equations. An example with logistic regression models is given in Section 3.5.

The initial doubly robust TATE estimator is obtained from the site-specific ATE of the target sites. Within target site k t ∈ T , we compute the doubly robust TATE (Bang & Robins 2005) 

is the OR model based estimate of the TATE, and

is the augmentation term that guards against mis-specification of the OR model. In addition, we calculate summary statistics for the k t ∈ T target site covariate distribution,

The AC can construct the initial TATE estimate,

with summary data from target sites, { ∆ T ,k t , n k t : k t ∈ T }. The consistency of ∆ T ,T is ensured when either the PS or OR is consistently estimated for each k t ∈ T .

Remark 3. Here, we estimate β a in each target site k t ∈ T as β a,k t . Alternatively, one could estimate β a jointly at the cost of one additional round of communication between target sites. A jointly estimated β a could benefit from efficiency gain under certain model specification conditions. Previous literature have developed distributed methods for aggregating estimates of β a (Chen et al. 2006 , Huang & Huo 2019 , Duan et al. 2020a .

In practice, one should balance the advantage of potential efficiency gain with the cost of an additional cross-site communication.

To facilitate optimal aggregation, we also share the estimators for the variancecovariance of scaled estimators √ n k t ( M T ,k t , δ T ,k t , ψ k t , β 1,k t , β 0,k t ), which we denote as Σ k t . Variance estimation Σ k t can be conducted through classical influence functions or bootstrapping within site. The exact role of the matrix in the aggregation will be unveiled after introducing the optimal combination weights in (S.9), which is the centerpiece of the adaptive aggregation step.

To safely use source data to assist in estimating ∆ T , we further account for the covariate shifts between the source sites and the target sites by tilting the source sites to the target population through the density ratios ω k t ,ks (X; γ k t ,ks ). If individual-level data can be shared, estimating γ ks could be achieved by constructing a pseudo-likelihood function as in Qin (1998) . However, such an estimator cannot be directly obtained in a federated data setting.

Instead, we propose a simple estimating equation approach that can be calculated in each source site k s ∈ S using its data, along with summary statistics ψ k t obtained from the target sites k t ∈ T . Specifically, we estimate γ k t ,ks as γ k t ,ks : solution to n −1 ks i∈I ks ω k t ,ks ψ(X i ); γ k t ,ks ψ(X i ) = ψ T ,k t . (S.6) For the k s ∈ S source site, we construct a site augmentation term similar to the augmentation term in (S.5) for the target sites but with an additional density ratio weight

We use the OR estimates from target sites β A i ,k t to ensure robustness when the OR is mis-specified. See Remark 4 for details.

Then, the site-specific augmentation terms δ T ,ks are shared back to the AC, together with (i) σ 2 ks , an estimate for the scaled conditional variance n ks Var δ T ,ks | D T , and (ii) d k t ,ks , an estimate for the partial derivatives of δ T ,ks with respect to ψ k t , β 1,k t , and β 0,k t .

The role of d k t ,ks in the aggregation will be explained in (S.9). Both σ 2 ks and d k t ,ks can be constructed from classical influence functions. Alternatively, σ 2 ks can be estimated by bootstrapping within site and d k t ,ks can be estimated by numerical derivatives.

Remark 4. Combining the source site augmentation term δ T ,ks with the initial TATE OR estimator from the target sites M T ,T , we obtain the k s ∈ S source site estimators ∆ T ,ks = M T ,T + δ T ,ks as

When the underlying OR model in the k s -th source site is the same as in the target population, the estimator ∆ T ,ks is doubly robust in the following sense: either (i) the OR model is consistent for all k ∈ {T , k s }, or (ii) the PS and density ratio models are consistent for the source site. Shifts in covariate distributions may induce heterogeneity in OR estimates across sites under mis-specified OR models, even if the conditional distribution Y | A, X is shared. To achieve robustness toward mis-specified OR, it is important to use the same β a,k t for M T ,T and δ T ,ks so that we may rely on the correct PS and density ratio models for consistency according to the alternative representation

To protect against negative transfer from source sites with biased TATE estimators, we combine information from each source site with the target sites through our adaptive aggregation step in Section 3.3.

In the final step, we obtain our FACE estimator by adaptively aggregating the initial TATE estimator ∆ T ,T and the source site estimators ∆ T ,ks . Denote δ T ,

AC can estimate ∆ T by an "anchor and augmentation" estimator

which anchors on the target TATE estimator ∆ T ,T with the weights {η ks , k s ∈ S} to be estimated in a data-adaptive fashion to filter out potentially biased source site estimators.

The second expression of ∆ T ,FACE in (S.7) shows how the parameters from Steps 1 and 2 are used in the construction of the FACE estimator.

Moreover, the aggregation of the remaining unbiased source site augmentation terms should also minimize the estimation variance. Under the federated learning setting, the key to evaluate the variance of S.7 is to decompose it into contributions from separate sites so that they can be estimated within each site. For any subset of S, S ⊆ S, we consider the following decomposition

where d k t ,ks is the limit for d k t ,ks , which is the partial derivative of δ T ,ks with respect to broadcast estimators ψ k t , β 1,k t and β 0,k t . We decouple the dependence of the source site augmentation terms δ k t ,ks on the target sites by subtracting the first order approximation of the dependence ψ k t , β 1,k t , β 0,k t d k t ,ks . The resulting δ T ,ks − d k t ,ks ψ is asymptotically independent of the target sites.

Since including information from source sites S \ S * may lead to biases, we adopt an adaptive combination strategy similar to the one given in Cheng & Cai (2021) for combining data from a randomized trial and an observation study. Here, we overcome the additional challenge of data sharing constraints, and we propose the following adaptive L 1 penalized optimal aggregation η = arg min

with Σ k t estimated from Step 1 and σ 2 ks and d k t ,ks estimated from Step 2. The multiplicative N factor is required to stabilize the loss. Choosing λ N ν with ν ∈ (0, 1/2), we achieve the following oracle property for selection and aggregation: (i) biased source site augmentation terms have zero weights with high probability; (ii) regularization on the weights for unbiased source site augmentation terms is asymptotically negligible ( N −1/2 ).

Analogous to the phenomenon in meta-analysis, the estimation uncertainty of η has no asymptotic effect on the aggregated estimator.

Using the variance estimator (stabilized by "N " factor likewise)

and the 1 − α/2 quantile for the standard normal distribution Z α/2 , we construct the

The full FACE workflow is summarized in Algorithm 1.

Remark 5. Our aggregation procedure is communication-efficient and privacy-protected, whereas aggregation procedures given in the current literature such as those in Cheng & Cai (2021) require sharing individual-level influence functions. Equation (S.9) is constructed using summary statistics, which provides a federated learning solution when individual-level data sharing is forbidden.

Algorithm 1 FACE under generic model specifications Data: J target sites k t ∈ T , K source sites k s ∈ S, and a Leading AC 1 for Target k t ∈ T do 2 Estimate α k t , β a,k t to calculate the initial TATE ∆ T ,k t its augmentation δ T ,k t and the variance estimator Σ k t and transfer to the leading AC. Calculate ψ k t and broadcast to source sites along with β a,k t .

3 end 4 for Source sites k s ∈ S do 5 Estimate γ k t ,ks and α ks to calculate the site-specific augmentation δ T ,ks and transfer to the leading AC. Calculate σ 2 ks , d k t ,ks and transfer to the leading AC. 6 end 7 for Leading AC do 8 Estimate η by solving the penalized regression in (S.9). Construct the final global estimator as ∆ T ,FACE by (S.7). Calculate the global estimator variance by (S.10) and construct 95% CI. 9 end Result: Global TATE estimate, ∆ T ,FACE and 95% CI

To choose an optimal tuning parameter λ, we propose a sample splitting approach that does not require sharing individual-level data. In each site, the data is first split into training and validation datasets, keeping the same proportion within each site. In the training datasets, Algorithm 1 is implemented to obtain the summary statistics ( Σ k t , d ks , σ 2 ks , δ T ,ks , and δ T ,T ) needed for Equation (S.9). The AC selects a grid of λ values satisfying λ N ν with ν ∈ (0, 1/2) and calculates η(λ) by solving the penalized regression in (S.9). In parallel, the validation datasets are used to obtain summary statistics denoted by (Σ k t ,d k t ks ,σ 2 ks , δ T ,ks andδ T ,T ). These summary statistics are calculated using the validation datasets and plugging in the parameters estimated from the corresponding training datasets. The AC sets the value of the optimal tuning parameter, λ opt , to be the value corresponding to the η that minimizes Q( η) in the validation datasets, defined as

where N V , n V ks , and n V k t are the sample sizes for validation data from all sites, source site k s , and target site k t , respectively.

As an example, we illustrate FACE under logistic regression models with Y being binary, J + K = 5 total sites and T = {1} as the target site. For notational ease, let X be the vector of covariates with an intercept term. We fit logistic regression models with link g(x) = 1/(1 + e −x ) and loss (y, x) = log(1 + e x ) − yx for all PS and OR models. For simplicity, we let ψ(X) = X.

In

Step 1, we calculate the mean covariate vector in the target site k t = 1 as ψ T = 1 n 1 i∈I 1 X i and transfer it to sites 2 through 5. Then, we estimate the models for k t = 1

Using the estimated models, we obtain the initial estimator and its augmentation term

, and the exact form of ξ i,1 , ζ i and υ a,i are given in the Supplement C.4.

In

Step 2, we estimate the models for k s = 2, . . . , 5

Using the estimated models, we obtain the the site-specific augmentations

along with the partial derivative of δ T ,ks with respect to ψ T , d ks = ( d ks,ψ , d ks ,β 1 , d ks ,β 0 ) , as

The variance estimator σ 2 ks can be calculated as σ 2 ks = n −1 k t i∈I ks ξ 2 i,ks through the estimated influence function, where the form of ξ i,ks is given in the Supplement C.4.

In

Step 3, we use Σ 1 , d ks , σ 2 ks , δ T ,ks and δ T ,T to solve the adaptive selection and aggregation (S.9), which leads to ∆ T ,FACE and the confidence interval C α .

In this section, we provide the theoretical results for the FACE estimator. We start with a high-level theory for a generic choice of models in Section 4.1. Then, we discuss the efficiency gain from leveraging source sites in Section 4.2. We give in Section B.2 a detailed set of conditions corresponding to the realization of Section 3.5. In our asymptotic theory, N is allowed to grow but the distribution for (Y, X , A, R) and J + K are fixed.

To compress the notation, we combine the broadcast parameters and their asymptotic limits as

Regularity conditions are detailed in Assumption S1 of the Supplementary Materials.

We now state the theory for the general FACE estimation.

Theorem 1. Under Assumptions 1 and S1, the FACE estimator is consistent and asymptotically normal with consistent variance estimation V,

We use for convergence in distribution.

Theorem 1 implies that (S.11) provides asymptotically honest coverage.

Corollary S1. Under Assumptions 1 and S1, the coverage rate of the confidence interval (S.11) approaches the nominal level asymptotically

A key step in the proof of Theorem 1 is the analysis of the L 1 penalized adaptive selection and aggregation (S.9). We are able to establish the oracle property (Fan & Li 2001) , i.e., the data-driven selection and aggregation through (S.9) is asymptotically equivalent to the process with a priori selection and optimal aggregation. The problem is different from the typical penalized regression, so we develop a new proof strategy. We first analyze the optimal combination with oracle selection, in which the biased augmentations are excluded. For unbiased augmentations, ∆ T ,ks − ∆ T ,T = O p (N −1/2 ), so the penalty term is

with ν ∈ (0, 1/2). Thus, the estimated combination converges to the asymptotic limit at the regular N −1/2 rate. Finally, we show that the estimated combination with oracle selection also solves the original problem with high probability.

Remark 6. For consistency of ∆ T ,FACE , we require that the PS or OR model is correct for the target sites but allow the models for the source sites and density ratio to be mis-specified.

To meaningfully leverage information from source sites for the TATE, we would expect that many k s ∈ S among the source sites (i) satisfy the ignorability condition 1(d) and (ii) either the OR model m(a) is correct, or both the PS π ks and the density ratio ω k t ,ks models are correct. For source sites satisfying the conditions above, their site-specific augmentations are unbiased and thus contribute to the efficiency improvement of ∆ T ,FACE .

Notice that we recover the initial TATE estimator ∆ T ,T from (S.7) if η = 0. Since we are minimizing the post-aggregation variance, the optimal solution must be no worse than any alternative solutions. If there exists informative source sites in S , as defined in Assumption S2, improvement in the efficiency of FACE compared to the target only estimator is guaranteed.

Proposition 1. Under the conditions of Theorem 1, the asymptotic variance of ∆ T ,FACE is no larger than that of ∆ T ,T . Moreover, if Assumption S2 holds, the asymptotic variance of ∆ T ,FACE is strictly smaller than that of ∆ T ,T .

Proposition 1 offers a guarantee on the relative efficiency in general settings. As the exact efficiency gain may take different forms under general settings, we showcase the efficiency gain with a clear interpretation under a simple ideal setting. When models are correctly specified, we have an explicit form for the oracle optimal combination η and the improvement in estimation efficiency for the TATE.

Assumption 3. The PS, OR, and density ratio models are consistently estimated at √ N rate:

Under Assumptions 1-3, the optimal combination asymptotically approaches

The efficiency of FACE relative to the initial TATE estimator is

Resulting from independence under the ideal setting, the weights {1 − η, η} coincide with the inverse variance weights for { δ T ,1 , δ T ,2 }. According to Proposition 2, the relative efficiency of FACE is monotone increasing in n S /V 2 S . When n S increases, the relative efficiency approaches 1+V 2 T /V 2 m . In that case, the asymptotic variance of FACE approaches V 2 m /P(R ∈ T ), the asymptotic variance of M T ,T . Under the ideal setting, the two components in the initial TATE estimator, outcome regression M T ,T and augmentation δ T ,T , are independent. The FACE estimator includes the source site data to improve the augmentation component, leading to a reduction in its asymptotic variance.

We study the finite sample performance of the FACE estimator and make comparisons with an estimator that leverages target data only and a sample-size adjusted estimator that does not adaptively weight different sites. In the simulation studies, we take the target population to be a single site. We examine the empirical bias, empirical standard error (ESE), average of the estimated standard error (ASE), and coverage probability (CP) of the 95% CI over 1, 000 simulations. We vary the number of source sites K ∈ {5, 10, 50}, the true OR, PS, and density ratio models, and the number of source sites with correctly specified models.

To allow for heterogeneity in the covariate distribution between sites, the covariates in each site X kp are generated from a skewed normal distribution, X kp ∼ SN (x; κ kp , φ 2 kp , ν kp ),

where k = 1, ..., J + K indexes the sites and p = 1, ..., 10 indexes the ten covariates, κ kp is the location parameter, φ kp is the scale parameter, and ν kp is the skewness parameter. For all sites, we let κ k· ∈ (0.10, 0.15) and φ k· = (1, ..., 1). For the target site, we set ν k· = 0.

For the source sites, we let ν k· ∈ {−0.25, 0.25}. Under these settings, the exponential tilt model provides a good approximation quality for projecting the source site covariate distribution to the target site. We fix the sample size in the target site and source sites to be n k t = n ks = 200.

The true potential outcomes are generated as

where X •2 k denotes X k squared element-wise, β 11 = (0.4, .., 1.2), and β 10 = (0.4, .., 1.2) with equally-spaced increments for a length 10.

The true PS model is generated as

where for the target site, α 11 = (0.4, ..., −0.4), with equally-spaced decrements for a length 10 and α 21 = 0. For the source sites, α 1k = (0.5, ..., −0.5), with equally-spaced decrements for a length 10 and α 2k = 0 . For all sites, we fit linear regression models for the OR and logistic regression models for the PS, where we only include the linear terms of the covariates X k .

Since the specified OR and PS models do not include the quadratic terms, we consider a correct OR by setting β 21 = β 20 = 0; a correct PS by setting α 2k = 0; a mis-specified OR by setting β 21 = (0.2, .., 0.4) and a mis-specified PS by setting α 2k = (0.12, ..., −0.12).

We consider the following settings. In Setting 1, we examine the scenario where both the OR and PS models are correctly specified for all sites. In Setting 2, we mis-specify the OR while keeping the PS correctly specified for all sites. In Setting 3, we mis-specify the PS and correctly specify the OR for all sites. In Setting 4, the OR and PS models are mis-specified for half of the source sites. To examine the effect of increasing the number of mis-specified source sites, in Setting 5, the OR and PS models are mis-specified in all of the source sites.

In each setting, we choose the tuning parameter λ by the distributed cross validation procedure described in Section 3.3 from {0, 10 −4 , 10 −3 , 10 −2 , 0.1, 0.25, 0.5, 1, 2, 5, 10}, where we split the simulated datasets in each site into two equally sized training and validation datasets.

In and close to nominal coverage. Given that the sample size in each site is n k t = n ks = 200, K = 50 is a relatively large number of sites. Our theory requires K to be fixed, so bias can be introduced when K is large since the difference between the estimated and optimal weights grows with K. However, such bias reduces if we increase the sample size, which has been validated in an additional simulation with sample size increasing to 400.

Further, as displayed in Figure 1 , FACE shows decreasing variance as the number of source sites K increases, showing the potential benefit of leveraging additional source sites.

The precision gain holds across different model mis-specification scenarios (Settings 1-4). 

In this paper, we have developed FACE to leverage heterogeneous data from multiple study sites to more precisely estimate treatment effects for a target population of interest. FACE accounts for heterogeneity in the distribution of covariates through a density ratio weighting approach and protects against distributional heterogeneity and model mis-specification of the source sites through an adaptive integration strategy. It improves upon the precision of the target-population only estimator by leveraging source population information without inducing bias. FACE is privacy-preserving and communication-efficient, requiring only one round communication of aggregated summary statistics between sites. In addition to providing theoretical double robustness and efficiency guarantees, FACE does not rely on prior knowledge of model stability or correct model specification, which is a substantial improvement on current federated methods for causal inference (Xiong et al. 2021 is an important estimand of real-world interest, particularly for understanding benefits and dangers of treatments for underrepresented groups and fairness research.

The Supplementary Materials are divided into four sections. In Section A, we illustrate the workflow of FACE to construct a global estimator in a federated data setting. In Section B, we detail the regularity conditions needed for the theoretical results in Section 4 of the main paper. In Section C, we provide proofs for the theoretical results in Section 4 of the main paper. In Section D, we provide supplementary tables corresponding to the real data analysis. 

The Supplementary Materials are divided into four sections. In Section A, we illustrate the workflow of FACE to construct a global estimator in a federated data setting. In Section B, we detail the regularity conditions needed for the theoretical results in Section 4 of the main paper. In Section C, we provide proofs for the theoretical results in Section 4 of the main paper. In Section D, we provide supplementary tables corresponding to the real data analysis.

Figure S1: Workflow of FACE to construct a global estimator in a federated data setting

Assumption S1. For absolute constants M, ε > 0, (a) (Regularity of estimators) The estimators M T ,T , δ T ,k t , β a,k t and δ T ,ks admit the following approximations by influence functions

with bounded asymptotic limits M T ,T , δ T ,T , δ T ,ks , d k t ,ks and iid mean zero random variables ζ i , ξ i,T , ξ i,ks . 

has eigenvalues all in [ε, M ] for some positive constant ε and M .

(d) (Regularity of auxiliary estimators) The estimators Σ k t , σ 2 ks , d ks are

(e) (Double robustness) For each target site k t ∈ T , at least one of the two models is correctly specified:

-i the PS model is consistently estimated:

-ii the OR model is consistently estimated:

Assumptions S1(a) and S1(e) are the typical regularity conditions under classical parametric models. They can be verified in two steps: 1) asymptotic normality of model estimators (Van der Vaart 2000) and 2) local expansion of the estimators. Assumption S1(c) regulates the scale of variability of the data, which leads to a stable variance for ∆ T ,FACE . Assumption S1(e) ensures identification of the true TATE by anchoring on ∆ T ,T (Bang & Robins 2005) . Note that in the setting of multiple target sites, Assumption S1(e) allows for each target site to have different correct model specifications for either the OR model or the PS model.

Assumption S2. For a nonempty set S ⊆ S, one of the following holds (a) (i) Correct OR: the OR model is consistently estimated:

(ii) Consistent weighting: the PS and density ratio models are consistently estimated:

(b) Informative source: Let ϑ = (ψ(X) , υ 1 , υ 0 ) be the combined influence function for broadcast estimators. For all k s ∈ S

The two model consistency conditions in Assumption S2(a) ensure the consistency of the doubly robust estimator ∆ T ,ks . Assumption S2(b) characterizes the informativeness of a source site k s such that the updated direction δ T ,ks − δ T ,T is correlated with the initial ∆ T ,T . The covariance in the condition is likely to be negative with the opposite sign of ξ T .

For the special case with logistic regression models given in Section 3.5, we denote the asymptotic parameters as

We give a mild set of sufficient conditions for Assumption S1. (b) (Overlap) For all k = 1, . . . , J + K, a = 0, 1 and i ∈ I k , g(α k X i ), g (β a,k X i ) and

exp{γ ks X i } are in [ε, 1 − ε] almost surely.

(c) (Double robustness) For each target site k t ∈ T , at least one of the two models is correctly specified:

-i the PS model is correct:

After verifying that Assumptions 1 and S2 imply the generic Assumption S1, we can apply Theorem 1 in that realization.

Corollary S2. Under the setting of Section 3.5 and Assumptions 1 and S2, the FACE estimator is consistent and asymptotically normal with consistent variance estimation V,

In this section, we provide proofs for the theoretical statements in the main text. In Sections C.1 and C.2, we declare and prove the key preliminary results. We then use these results to prove Theorem 1 and Corollary S1 in Section C.3, Corollary S2 in Section C.4, Proposition 1 in Section C.5 and Proposition 2 in Section C.6 C.1 Double Robustness of ∆ T ,T and ∆ T ,k s

We first establish the consistency and asymptotic normality of the initial TATE estimator ∆ T ,T and source site TATE estimator ∆ T ,ks .

Lemma S1. Under Assumptions 1, S1(a)-S1(c) and S1(e),

with asymptotic variance

Proof of Lemma S1. From the influence function representation in Assumption S1(a)

where ∆ T ,T is the asymptotic limit, and the stable variance in Assumption S1(c)

we have the asymptotic normality of ∆ T ,T

Under the typical Assumptions 1(a), 1(b), 1(d) and S1(e), the doubly robust estimator ∆ T ,T converges to the TATE ∆ T (Bang & Robins 2005) . Thus, we must have ∆ T ,T = ∆ T .

Lemma S2. Under Assumptions 1 and S1(a)-S1(c),

with ∆ T ,ks = ∆ T − δ T ,T + δ T ,ks and

Additionally under Assumption S2(a), ∆ T ,ks = ∆ T for k s ∈ S .

Proof of Lemma S2. From the influence function representation in Assumption S1(a)

and the stable variance in Assumption S1(c) Var (ξ i,ks | R = k s ) ∈ [ε, M ] and Var

we have the asymptotic normality of ∆ T ,ks

Similar to ∆ T ,T , the source site estimator ∆ T ,ks is also doubly robust under Assumptions 1 and S2(a).

When the OR model is consistently estimated under Assumption S2(a)(i) (same as Assumption S1(e)-ii) but the density ratio model and PS model may be mis-specified, we have through classical asymptotic analysis

In the derivation, we utilized Assumption 1(d) to establish the "= 0" by the identity

Denote ω * k t ,ks (X) =

, which produces the identity

When the PS and density ratio models are consistently estimated under Assumption S2(a)(ii) but the OR model may be mis-specified, we have through classical asymptotic analysis

Therefore in either case ∆ T ,ks = ∆ T .

We next consider the aggregation of the initial ∆ T ,T and the source site ∆ T ,ks . Denote

We define the oracle selection space for η as

and the asymptotic loss function

Any combination η ∈ R S * results in a consistent aggregated estimator for the TATE. The asymptotically optimal combination is

In Lemma S3, we establish the asymptotic distribution of the aggregated estimator with fixed η ∈ R S * . In Lemma S4, we show that the estimator η recovers the optimal η. In Lemma S5, we show that the uncertainty from η is negligible in estimating ∆ T as ∆ T ,FACE .

Lemma S3. Let ∆(η) = ∆ T ,T + ks ∈S η ks ∆ T ,ks − ∆ T ,T be the aggregation with η ∈ R S .

Under Assumptions 1 and S1, we have

Proof of Lemma S3. By Lemma S1, the initial estimator ∆ T ,T is consistent for ∆ T .

According to the definition of S * (S2), ∆ T ,ks is consistent for ∆ T for k s ∈ S * . Thus, the weighted average ∆(η) must also be consistent for ∆ T .

Next, we establish the asymptotic normality of ∆(η). From Assumption S1(a), we have the influence function for ∆(η)

.

We defined L * (η) to be precisely the variance of the influence function. To see this, we will show that L * (η) is the variance of 1 − k∈S η k ∆ T ,T + k∈S η k ∆ T ,k and use the influence function representation from Assumption S1(a). Denote η T = 1 − ks∈S η ks and define the asymptotic approximation of the aggregation under Assumption S1(a)

where we have merged by site and individual indices to obtain the last line. By this alternative representation of W (η), it is clear that its variance equals L * (η). Under

Assumption 1(c) and S1(c), L * (η) is stable

Further, under Asssumptions 1(c) and S1(a), we have

Hence for any bounded η, L * (η) is finite and nonzero, so we have

Lemma S4. Under Assumptions 1 and S1, we have

Proof of Lemma S4. We defineη as the estimator under oracle selectioñ

We first show that η − η = O p (N −1/2 ). Then, we verify thatη satisfies the optimality condition, i.e.,η = η, with high probability. Note that L(η) and L * (η) are both quadratic functions of η, which can be expressed as L(η) = η Hη + g η + c, L * (η) = η Hη + g η + c

Using Assumptions S1(d) and the Chebyshev inequality under Assumptions S1(a) and S1(c), it is clear that H, g, and c are √ N -consistent. Thus, L(η)−L * (η) (1+ η 2 )/ √ N , since H, g and c are bounded under Assumptions S1(a) and S1(c).

Under Assumptions 1(c) and S1(d), we have the uniform approximation of the loss in

By Lemmata S1 and S2, we have for k s ∈ S * δ T ,T − δ T ,ks = ∆ T ,T − ∆ T ,ks = O p (N −1/2 ) .

With λ N 1/2 , the penalty is small in the compact neighborhood of η

Combining (S6) and (S7), we have the approximation of the penalized loss

Following the convexity of L * (η) from Assumption S1(c), we have

The optimality condition of the original problem (S.7) is

For j ∈ S * , the conditions are shared with (S5), soη must satisfy them. To establish the optimality ofη for (S.7), it suffices to show

By the definition of S * , we have for biased sites δ T ,ks − δ T ,T = ∆ T ,ks − ∆ T ,T = 0.

By Lemmata S1 and S2, we have for k s ∈ S \ S *

bounded away from zero. With λ → ∞, the penalty for biased sites diverges for k s ∈ S \ S *

Under Assumptions 1(c), S1(c) and S1(d), the derivative is tight

Combining (S9) and (S10), we must have (S8) with high probability. This implies that η satisfies precisely the optimality condition with high probability. Therefore, we must have η =η according to the convexity of the problem with high probability.

Lemma S5. Under Assumptions 1 and S1,

Proof of Lemma S5. We decompose the difference into informative source sites k s ∈ S * and biased source sites k s ∈ S \ S *

By the definition of S * (S2) and the conclusions of Lemmata S1 and S2, we have the tightness of terms for k s ∈ S *

Applying the conclusion of Lemma S4, we have for k s ∈ S * 

Applying Lemmata S3 and S5, we have the asymptotic normality of ∆ T ,FACE , √ N ∆ T ,FACE − ∆ T N (0, L * (η)) .

Using the consistency of η for η and locally uniform convergence of L for L * (see (S1)-(S4)

for the definitions), we have the consistency of the variance estimator V = L( η) = L * (η) + O p (N −1/2 ) .

By the continuous mapping theorem, we have N/ V ∆ T ,FACE − ∆ T N (0, 1) .

The coverage probability in Corollary S1 immediately follows.

In the main text, we noted that the variance covariance matrix for the target site, Σ 1 can be calculated as as Σ 1 = 1 n 2 T i∈I 1 U i U i through the estimated influence functions, where U i = ( ζ i , ξ i , ψ(X i ) ) . Here, we provide the exact form for ξ i,1 and ζ i .

A j g α 1 X j g β 1,1 X j X j υ i,1 + 1 n T j∈I 1 1 − A j g − α 1 X j g β 0,1 X j X j υ i,0 , ζ i = g β 1,1 X i − g β 0,1 X i + 1 n T j∈I 1 g β 1,1 X j X j υ i,1 − 1 n T j∈I 1 g β 0,1 X j X j υ i,0 ,

For source sites, the variance estimator σ 2 k can be calculated as σ 2 k = 1 n k i∈I k ξ 2 i,k , where ξ i,k is

As Assumption S1 is satisfied, the FACE estimator is consistent and asymptotically normal with consistent variance estimation V, N/ V ∆ T ,FACE − ∆ T N (0, 1).

Since the initial estimator ∆ T ,T corresponds to ∆(0), the asymptotic variance of √ N ( ∆ T ,T − ∆ T ) can be expressed as L * (0) by Lemma S3. By Lemmata S3 and S5, the asymptotic variance of √ N ( ∆ T ,FACE − ∆ T ) is L * (η). By the definition of η as the minimum, we must have L * (η) ≤ L * (0). Thus, we have shown the non-inferiority of ∆ T ,FACE .

To show that L * (η) is strictly smaller than L * (0), it suffices to find anotherη, an upper bound for L * (η) by the definition of η, such that L * (η) ≤ L * (η) < L * (0). (S11)

Without loss of generality, we consider the simplified problem with one source site k * ∈ S , ∆(η) = ∆ T ,T + η ∆ T ,k * − ∆ T ,T .

Under Assumption S2(a), the TATE estimator of the site ∆ T ,k * is consistent for ∆ T and asymptotically normal by Lemma S2. Thus,∆(η) is also consistent for ∆ T and asymptotically normal with any η. The optimal η is given by the projection

We can constructη to be η * for site-k * and zero elsewhere such that ∆(η) =∆(η * ). As long as Cov ∆ T ,T , ∆ T ,k * − ∆ T ,T = 0, the resulting estimator is different from the initial estimatorη = 0 ⇒ ∆(η) = ∆ T ,T . Under Assumption 1(c) and S1(a), the asymptotic covariance between √ N ∆ T ,T and √ N ∆ T ,k * − ∆ T ,T takes the form Cov ζ + ξ T P(R ∈ T )

, − ξ T P(R ∈ T ) + k t ∈T I(R = k t ) P(R = k t ) (ψ(X) , υ 1 , υ 0 ) d k t ,k * | R ∈ T .

which is bounded away from zero by Assumption S2(b). Thus, we have found the suitablě η that separates the asymptotic variance of ∆ T ,FACE and ∆ T ,T through (S11).

Under the ideal setting of Assumption 3, the influence functions of the doubly robust ∆ T ,T and ∆ T ,2 admit much simpler forms (Robins et al. 1994 ) as a result of Neyman Orthogonality (Chernozhukov et al. 2018) ,

The asymptotic variance of the aggregation

Minimizing the quadratic function of η give the optimal solution η = n S V 2 T n S V 2 T + n T V 2 S .

We obtain the relative efficiency through 

Combining experimental and observational data to estimate treatment effects on long term outcomes

Doubly robust estimation in missing data and causal inference models

A split-and-conquer approach for analysis of extraordinarily large data

ODAL: A one-shot distributed algorithm to perform logistic regressions on electronic health records data from multiple clinical sites

A fast score test for generalized mixture models

Variable selection via nonconcave penalized likelihood and its oracle properties

Causal inference: What if

Characterizing treatment pathways at scale using the ohdsi network

A distributed one-step estimator

Causal inference in statistics, social, and biomedical sciences

A calibration approach to transportability with observational data

Communication-efficient sparse regression

Statistical inference in massive data sets

Divide-and-conquer for debiased l 1-norm support vector machine in ultra-high dimensions

Effectiveness of covid-19 vaccines over a 9-month period in north carolina

On the application of probability theory to agricultural experiments

A survey on transfer learning

Inferences for case-control and semiparametric two-sample density ratio models

Hypothesis testing in a mixture case-control model

Estimation of regression coefficients when some regressors are not always observed

Estimating causal effects of treatments in randomized and nonrandomized studies

Generalizability of randomized trial results to target populations: design and analysis possibilities

Assessing the generalizability of randomized trial results to target populations

The use of propensity scores to assess the generalizability of results from randomized trials

Asymptotic statistics

Federated estimation of causal effects from observational data

Distributed inference for linear support vector machine

A survey of transfer learning

2%) 60-69 35,709 (25.0%) 35,092 (27.2%) 29,943 (24.3%) 24,670 (26.3%) 27,906 (23.4%) 70-79 59,765 (41.8%) 50,839 (39.5%) 54,588 (44.3%) 36,230 (38.6%) 49,522 (41.5%) 80 or older 18

8%) 84,695 (90.3%) 105,503 (88.3%) Urbanicity Rural

2%) 39,267 (30.5%) 41,912 (34.0%) 27,124 (28.9%)

3%) Hypertension 104,775 (73.2%) 97,584 (75.8%)

0%) 45,952 (37.3%)

Chronic lung diseases (CLD) included asthma, bronchitis, and chronic obstructive pulmonary disease

CVD) included acute myocardial infarction, cardiomyopathy, coronary heart disease, heart failure, and peripheral vascular disease

Autoimmune diseases included HIV infection, rheumatoid arthritis, etc. The full list of ICD-10 codes are given in the Supplement

3%) 60-69 18,442 (26.4%) 17,267 (23.6%) 16,371 (27.1%)

5%) 14,093 (30.4%) 14,598 (25.4%) 16,182 (26.1%) CVD 18,573 (26.6%) 21,992 (30.1%) 16,902 (27.9%) 19,265 (28.2%) 17,335 (30.0%) 21,177 (32.4%) 12,546 (26.5%)

2%) 24,415 (35.7%) 21,260 (36.7%) 24,692 (37.8%) 14,912 (31.5%)